GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00096156 | Lung | IAC | response to virus | 61/2061 | 367/18723 | 6.75e-04 | 9.12e-03 | 61 |
GO:00465963 | Lung | IAC | regulation of viral entry into host cell | 12/2061 | 42/18723 | 1.44e-03 | 1.55e-02 | 12 |
GO:00354551 | Lung | IAC | response to interferon-alpha | 7/2061 | 21/18723 | 5.59e-03 | 4.12e-02 | 7 |
GO:001603213 | Lung | AIS | viral process | 85/1849 | 415/18723 | 4.74e-11 | 1.95e-08 | 85 |
GO:001905813 | Lung | AIS | viral life cycle | 68/1849 | 317/18723 | 5.39e-10 | 1.16e-07 | 68 |
GO:004671813 | Lung | AIS | viral entry into host cell | 38/1849 | 144/18723 | 1.13e-08 | 1.68e-06 | 38 |
GO:005212613 | Lung | AIS | movement in host environment | 43/1849 | 175/18723 | 1.29e-08 | 1.88e-06 | 43 |
GO:005170113 | Lung | AIS | biological process involved in interaction with host | 47/1849 | 203/18723 | 2.09e-08 | 2.90e-06 | 47 |
GO:004440913 | Lung | AIS | entry into host | 38/1849 | 151/18723 | 4.50e-08 | 5.24e-06 | 38 |
GO:004440313 | Lung | AIS | biological process involved in symbiotic interaction | 58/1849 | 290/18723 | 1.33e-07 | 1.44e-05 | 58 |
GO:005079213 | Lung | AIS | regulation of viral process | 32/1849 | 164/18723 | 1.33e-04 | 2.97e-03 | 32 |
GO:004390312 | Lung | AIS | regulation of biological process involved in symbiotic interaction | 16/1849 | 72/18723 | 1.50e-03 | 1.81e-02 | 16 |
GO:001907913 | Lung | AIS | viral genome replication | 24/1849 | 131/18723 | 2.14e-03 | 2.30e-02 | 24 |
GO:005237212 | Lung | AIS | modulation by symbiont of entry into host | 12/1849 | 49/18723 | 2.39e-03 | 2.48e-02 | 12 |
GO:190390013 | Lung | AIS | regulation of viral life cycle | 26/1849 | 148/18723 | 2.64e-03 | 2.68e-02 | 26 |
GO:001905823 | Lung | AAH | viral life cycle | 21/613 | 317/18723 | 1.85e-03 | 4.31e-02 | 21 |
GO:001905833 | Lung | MIAC | viral life cycle | 36/967 | 317/18723 | 8.00e-06 | 7.07e-04 | 36 |
GO:005212623 | Lung | MIAC | movement in host environment | 23/967 | 175/18723 | 3.58e-05 | 1.97e-03 | 23 |
GO:004671823 | Lung | MIAC | viral entry into host cell | 19/967 | 144/18723 | 1.58e-04 | 6.13e-03 | 19 |
GO:001603223 | Lung | MIAC | viral process | 39/967 | 415/18723 | 2.34e-04 | 7.89e-03 | 39 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
FITM2 | SNV | Missense_Mutation | | c.645N>A | p.Asn215Lys | p.N215K | Q8N6M3 | protein_coding | deleterious(0) | benign(0.089) | TCGA-A8-A07J-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | 5-fluorouracil | CR |
FITM2 | insertion | Frame_Shift_Ins | novel | c.72_73insGCGAACCTCGTCTCTTCTAAAA | p.Pro25AlafsTer134 | p.P25Afs*134 | Q8N6M3 | protein_coding | | | TCGA-AN-A0FK-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
FITM2 | insertion | Frame_Shift_Ins | novel | c.70_71insAGCCTGTCCAACA | p.Leu24GlnfsTer132 | p.L24Qfs*132 | Q8N6M3 | protein_coding | | | TCGA-AN-A0FK-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
FITM2 | SNV | Missense_Mutation | rs370245406 | c.487N>A | p.Ala163Thr | p.A163T | Q8N6M3 | protein_coding | tolerated(0.26) | benign(0.04) | TCGA-A6-5665-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
FITM2 | SNV | Missense_Mutation | rs771219892 | c.253N>A | p.Gly85Ser | p.G85S | Q8N6M3 | protein_coding | tolerated(0.43) | possibly_damaging(0.593) | TCGA-CM-6162-01 | Colorectum | colon adenocarcinoma | Female | <65 | III/IV | Chemotherapy | oxaliplatin | SD |
FITM2 | SNV | Missense_Mutation | novel | c.118N>A | p.Glu40Lys | p.E40K | Q8N6M3 | protein_coding | deleterious(0.02) | possibly_damaging(0.631) | TCGA-A5-A0G1-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
FITM2 | SNV | Missense_Mutation | novel | c.581N>T | p.Ala194Val | p.A194V | Q8N6M3 | protein_coding | deleterious(0) | possibly_damaging(0.611) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
FITM2 | SNV | Missense_Mutation | novel | c.152N>G | p.Asn51Ser | p.N51S | Q8N6M3 | protein_coding | tolerated(0.42) | benign(0.112) | TCGA-AJ-A3EK-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | carboplatin | CR |
FITM2 | SNV | Missense_Mutation | rs755374181 | c.539N>A | p.Arg180Gln | p.R180Q | Q8N6M3 | protein_coding | tolerated(0.4) | possibly_damaging(0.849) | TCGA-AP-A0LM-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | SD |
FITM2 | SNV | Missense_Mutation | novel | c.499G>A | p.Val167Ile | p.V167I | Q8N6M3 | protein_coding | tolerated(0.19) | benign(0.038) | TCGA-AX-A1CE-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unspecific | Paclitaxel | SD |